Loading...
Market
How many countries will adopt Abbott's Alinity m MPXV assay for mpox testing by end of 2024?
3
Resolution / Starting Odds
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Official health department announcements globally
Story
WHO Approves Abbott's Alinity m MPXV Assay as First Mpox Test for Emergency Use
Oct 4, 2024, 07:46 AM
The World Health Organization has approved the first diagnostic test for mpox, formerly known as monkeypox, under its Emergency Use Listing procedure, marking an important milestone in expanding global access to mpox testing amid rising outbreaks in Africa. The approved test, called the Alinity m MPXV assay, is manufactured by Abbott Molecular, a division of Abbott Laboratories. This emergency use authorization enables countries to detect the virus more quickly and effectively, strengthening their responses to outbreaks.
View original story
Similar markets
Less than 10 • 25%
10-20 • 25%
21-30 • 25%
More than 30 • 25%
1-3 countries • 25%
4-6 countries • 25%
7-9 countries • 25%
10 or more countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
16+ countries • 25%
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31+ countries • 25%
No countries • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
More than 10 countries • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
Less than 10 countries • 25%
10-20 countries • 25%
21-30 countries • 25%
More than 30 countries • 25%
India • 25%
South Africa • 25%
China • 25%
Brazil • 25%
0-2 countries • 25%
3-5 countries • 25%
6-8 countries • 25%
9 or more countries • 25%